US4507323A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Treatment of psychosexual dysfunctions
Assignee: SmithKline Beecham Corp
•
Filing: 1984-07-25
•
Granted: 1985-03-26
•
Expires: 2004-07-25
Abstract
Abstract A method of treatment of pychosexual dysfunction in male and female human beings by the administration of the compound of the formula (I) ##STR1## or a pharmaceutically acceptable acid addition salt thereof in a non-toxic, effective therapeutic amount (calculated as base) to a human being in need thereof.
Inventors
- 👤 Warren C. Stern
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 22:49
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/13; A61K31/135; A61P; A61P13/00; A61P13/02; A61P15/00
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
41 words
A method of treating psychosexual dysfunction in a human being suffering from same, which comprises administering to said human being an effective, non-toxic, sexual dysfunction therapeutic amount of the compound of the formula (I) ##STR3## or a pharmaceutically acceptable salt thereof.
Claim 2
Independent Claim
41 words
A method of treating psychosexual dysfunction in a human being suffering from same, which comprises administering to said human being an effective, non-toxic, sexual dysfunction therapeutic amount of the compound of the formula (I) ##STR3## or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim
13 words
The method of claim 1 in which a pharmaceutically acceptable salt is administered.
Claim 4
Dependent Claim
13 words
The method of claim 2 in which the salt is the hydrochloride salt.
Claim 5
Dependent Claim
19 words
The method of claim 1 in which the compound or salt is administered in a pharmaceutically acceptable carrier therefor.
Claim 6
Dependent Claim
18 words
The method of claim 2 wherein said compound or salt is administered in a pharmaceutically acceptable carrier therefor.
Claim 7
Dependent Claim
18 words
The method of claim 3 wherein said compound or salt is administered in a pharmaceutically acceptable carrier therefor.
Claim 8
Dependent Claim
14 words
The method of claim 1 in which the compound or salt is administered orally.
Claim 9
Dependent Claim
13 words
The method of claim 2 wherein said compound or salt is administered orally.
Claim 10
Dependent Claim
13 words
The method of claim 3 wherein said compound or salt is administered orally.
Claim 11
Dependent Claim
13 words
The method of claim 4 wherein said compound or salt is administered orally.
Claim 12
Dependent Claim
13 words
The method of claim 5 wherein said compound or salt is administered orally.
Claim 13
Dependent Claim
13 words
The method of claim 6 wherein said compound or salt is administered orally.
References Cited (Backward Citations)
US3819706A
Cited
US3885046A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1988-03-25 | 1988-09-24 | 1989-03-26 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1992-03-25 | 1992-09-24 | 1993-03-26 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1996-03-25 | 1996-09-24 | 1997-03-26 | $7700.00 | Window Closed / Lapsed |